Genmab — Juni 2020
-
I har ret begge to. Udvikling med Abbvie vil tage tid (hvilekt på ingen måde er et problem) men Genmab har (som Jan meget tydeligt fremhævede) allerede helt nye ting i pipeline, der ikke har været 'flagged' så næste Genmab ting er allerede på vej. Så de har ikke solgt alt ud.
-
GENMAB A/S GMAB.CO: JYSKE BANK RAISES TARGET PRICE TO DKK 2100 FROM DKK 1825; RATING HOLD - Reuters News
-
Hvis man får et nyt Black Swan event som sender hele markedet i hullet, kan det vel ikke udelukkes, men risikoen er i hvert fald mindre nu end før partner aftale.
-
Nej det gjorde jeg i hvert fald ikke Solsen, men det kan der jo heldigvis rettes op på!
-
Tusinde tak Solsen.

-
SEB raises target on Genmab from 1500 to 1900 keeps hold rating
-
Donation: https://www.proinvestor.com/donation.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind